Markets are wrestling with politics, inflation prints and bond yields all at once, while investors still need reliable income and lower volatility options. That mix can punish crowded trades and reward quieter corners of healthcare and utilities that pay dividends and carry regulated or defensive traits. This article walks through three U.S. stocks that are exposed to the latest news cycle and explains why each could matter for your watchlist right now.
The three stocks below are just a sample, and the full screen pulled out 58 more healthcare and utility companies with similar income and risk profiles that are not covered in this article. If you want to identify and analyze potential higher conviction defensive ideas right away, head straight to the U.S. Defensive, Dividend-Paying Healthcare and Utilities screener.
CVS Health brings together insurance, pharmacy benefit management, and a huge retail and clinic footprint. This combination is the kind of diversified healthcare platform many investors look for when they want steadier dividends and lower volatility exposure from this screener.
CVS Health generates most of its revenue from Health Services at about US$205.2b, Health Care Benefits at roughly US$144.8b, and Pharmacy & Consumer Wellness at around US$139.0b. Its market value is near US$107.3b and is supported by its U.S. focused operations.
"CVS Health has just faced a stock decline of about 10% after its preliminary Q3 earnings miss, which made the entire market aware. The decline is contributed largely to a $1.1 billion charge connected with its Medicare and Individual Exchange businesses and a whopping $1.2 billion restructuring charge for store closures."
The key question for investors is how the developing pressure inside the healthcare benefits arm will influence pricing power and profitability.
That pressure point is exactly why reading the full narrative for CVS Health can help you see whether this reset is masking a healthier, more resilient CVS Health story.
Medtronic gives this defensive healthcare screen a different flavor by pairing recurring device use in chronic care with a long-running dividend profile that many income-focused investors look for in medical technology.
Medtronic runs a broad medical devices platform across cardiovascular, neuroscience and surgical tools. It generates about US$14.6b from Cardiovascular, US$10.5b from Neuroscience, US$9.0b from Medical Surgical and US$3.4b from Other activities, with a market value near US$124.6b.
"The separation of the MiniMed diabetes business, which carries structurally lower margins and higher R&D intensity, together with SKU rationalization and design to cost programs, is expected to move Medtronic toward higher gross and operating margins and support faster EPS growth once the spin off is fully reflected in reported results."
One quiet shift in how Medtronic earns each extra dollar of revenue could tilt the entire margin story for this dividend payer.
That margin tilt is exactly why reading the full narrative for Medtronic can help you see whether Medtronic’s earnings mix is quietly accelerating a stronger long term dividend story.
American States Water is a regulated water and electric utility that lines up neatly with the screener’s focus on steadier, dividend paying infrastructure assets. It serves customers in California communities and military bases and carries a market value of about US$3.6b.
For investors hunting defensive income, American States Water offers rate based water and power operations, a long history of dividend increases and experienced management, all in a low beta utility. The main question is how that appeal holds up if one unseen pressure on its balance sheet or payout policy shifts.
That hinge point on the payout is exactly why reviewing the American States Water financial health report could reveal where American States Water’s next pressure or cushion really lies.
Fresh ideas move fast. The next breakout list can shift from under the radar to fully priced before the crowd even blinks, so act now and get in early.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com